Logo image of TLRY

TILRAY BRANDS INC (TLRY) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:TLRY - US88688T2096 - Common Stock

11.012 USD
+2.58 (+30.63%)
Last: 12/12/2025, 9:48:09 AM

TLRY Key Statistics, Chart & Performance

Key Statistics
Market Cap1.28B
Revenue(TTM)830.77M
Net Income(TTM)-2.15B
Shares116.00M
Float115.10M
52 Week High23.2
52 Week Low3.51
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-13.2
PEN/A
Fwd PEN/A
Earnings (Next)01-08 2026-01-08/bmo
IPO2018-07-19
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


TLRY short term performance overview.The bars show the price performance of TLRY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100

TLRY long term performance overview.The bars show the price performance of TLRY in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TLRY is 11.012 USD. In the past month the price decreased by -31.46%. In the past year, price decreased by -29.16%.

TILRAY BRANDS INC / TLRY Daily stock chart

TLRY Latest News, Press Relases and Analysis

TLRY Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 46.13 959.04B
JNJ JOHNSON & JOHNSON 20.3 507.79B
MRK MERCK & CO. INC. 11.32 247.43B
PFE PFIZER INC 8.08 147.03B
BMY BRISTOL-MYERS SQUIBB CO 8.04 107.44B
ZTS ZOETIS INC 19.03 53.18B
RPRX ROYALTY PHARMA PLC- CL A 9.37 22.24B
VTRS VIATRIS INC 4.98 13.38B
ELAN ELANCO ANIMAL HEALTH INC 22.19 10.59B
CORT CORCEPT THERAPEUTICS INC 98.38 9.11B
AXSM AXSOME THERAPEUTICS INC N/A 7.27B
BLTE BELITE BIO INC - ADR N/A 5.15B

About TLRY

Company Profile

TLRY logo image Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

Company Info

TILRAY BRANDS INC

265 Talbot Street West

Leamington ONTARIO V9X 1J2 CA

CEO: Irwin D. Simon

Employees: 2842

TLRY Company Website

TLRY Investor Relations

Phone: 15193228800

TILRAY BRANDS INC / TLRY FAQ

Can you describe the business of TILRAY BRANDS INC?

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


What is the stock price of TILRAY BRANDS INC today?

The current stock price of TLRY is 11.012 USD. The price increased by 30.63% in the last trading session.


Does TILRAY BRANDS INC pay dividends?

TLRY does not pay a dividend.


What is the ChartMill technical and fundamental rating of TLRY stock?

TLRY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What sector and industry does TILRAY BRANDS INC belong to?

TILRAY BRANDS INC (TLRY) operates in the Health Care sector and the Pharmaceuticals industry.


What is TILRAY BRANDS INC worth?

TILRAY BRANDS INC (TLRY) has a market capitalization of 1.28B USD. This makes TLRY a Small Cap stock.


What is the next earnings date for TLRY stock?

TILRAY BRANDS INC (TLRY) will report earnings on 2026-01-08, before the market open.


TLRY Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TLRY Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TLRY. TLRY has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TLRY Financial Highlights

Over the last trailing twelve months TLRY reported a non-GAAP Earnings per Share(EPS) of -13.2. The EPS decreased by -6498% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -103.13%
ROE -139.41%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%100%
Sales Q2Q%4.73%
EPS 1Y (TTM)-6498%
Revenue 1Y (TTM)2.31%

TLRY Forecast & Estimates

16 analysts have analysed TLRY and the average price target is 17.2 USD. This implies a price increase of 56.23% is expected in the next year compared to the current price of 11.012.

For the next year, analysts expect an EPS growth of 99.61% and a revenue growth 3.65% for TLRY


Analysts
Analysts71.25
Price Target17.2 (56.19%)
EPS Next Y99.61%
Revenue Next Year3.65%

TLRY Ownership

Ownership
Inst Owners10.33%
Ins Owners0.36%
Short Float %8.86%
Short Ratio1.32